These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 18704131

  • 21. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M, Carratala J.
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [Abstract] [Full Text] [Related]

  • 22. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A.
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [Abstract] [Full Text] [Related]

  • 23. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR.
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [Abstract] [Full Text] [Related]

  • 24. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
    Figuera Esparza M, Carballo M, Silva M, Figueredo A, Avilán J.
    Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
    [Abstract] [Full Text] [Related]

  • 25. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S, Palmer S, Ellis-Pegler R.
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [Abstract] [Full Text] [Related]

  • 26. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y, Yakushiji H, Ito Y, Kamimura T.
    Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
    [Abstract] [Full Text] [Related]

  • 27. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E, Schlegel L, Vekhoff A, Gerbal R, Marie JP, Bouvet A.
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [Abstract] [Full Text] [Related]

  • 28. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
    Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L.
    J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
    Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, von Baum H.
    J Antimicrob Chemother; 2005 Jan; 55(1):57-60. PubMed ID: 15574472
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 34. Microbiological data for patients with febrile neutropenia.
    Kanamaru A, Tatsumi Y.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S7-S10. PubMed ID: 15250014
    [Abstract] [Full Text] [Related]

  • 35. [Penicillin and aminoglycoside in febrile neutropenia].
    Torfoss D, Høiby EA, Holte H, Kvaløy S.
    Tidsskr Nor Laegeforen; 2008 Dec 04; 128(23):2738-40. PubMed ID: 19079423
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [Abstract] [Full Text] [Related]

  • 38. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R, Hassall T, Morland B, Gray J.
    Pediatr Hematol Oncol; 2003 Sep 15; 20(6):439-44. PubMed ID: 14631617
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Management of fever in neutropenic patients with different risks of complications.
    Klastersky J.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S32-7. PubMed ID: 15250018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.